| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/31/2001 | US6268138 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs |
| 07/31/2001 | US6268136 Methods for stool sample preparation |
| 07/31/2001 | US6268128 Immobilized oligonucleotide probes and uses thereof |
| 07/31/2001 | US6268125 Surface plasmon resonance device; for the detction of preferential particles in sample |
| 07/31/2001 | US6268123 Extraction, measurement; infection diagnosis |
| 07/31/2001 | US6268122 Synthetically generated polypeptide which display hepatitis viral antigenicity; for use in the detection of viral infection and vaccine preparation |
| 07/31/2001 | US6268121 Diagnostic device; for the detection of allergens in fluids |
| 07/31/2001 | US6268053 Blend of macromolecule and polymer |
| 07/31/2001 | US6267992 Administering metabolite of salviae miltiorrhizac radix herb to diabetic individual to treat diabetic nephropathy |
| 07/31/2001 | US6267969 In diagnostic assays to determine the presence and/or amount of substances interest in test samples |
| 07/31/2001 | US6267960 Administering monoclonal antibody designated atcc no. hb-12612, hb-12616, atcc no. hb12618, or atcc no. hb-12617 which binds specifically to extracellular domain of prostate stem cell antigen (psca) to inhibit growth of prostate tumor |
| 07/31/2001 | US6267946 Cultivating epstein-barr virus(ebv) genome-carrying cells in presence of tumor-promoting chemical or tumor-inducing chemical; treating ebv genome-carrying cells with synthetic colorant to reduce early antigen induction |
| 07/31/2001 | US6267929 Able to withstand prolonged incubation periods without separation of adhesive membrane from card surface |
| 07/31/2001 | US6267927 Apparatus for performing laboratory tests automatically |
| 07/31/2001 | US6267859 DNA sample preparation and electrophoresis analysis apparatus |
| 07/31/2001 | US6267858 High throughput screening assay systems in microscale fluidic devices |
| 07/31/2001 | US6267011 Method and apparatus for determining the true stress and true strain behavior of a ductile polymer |
| 07/31/2001 | US6266995 Portable medical gas system tester |
| 07/31/2001 | CA2333346A1 Interrogation of changes in the contents of a sealed container |
| 07/31/2001 | CA2184579C Medication delivery device with a microprocessor and characteristic monitor |
| 07/31/2001 | CA2151324C Magnetic material attracting/releasing control method making use of a pipette device and various types of clinical inspection apparatus using the method |
| 07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
| 07/31/2001 | CA2080933C Analyzer having cover |
| 07/31/2001 | CA2075193C Specimen test unit |
| 07/31/2001 | CA2055612C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus |
| 07/31/2001 | CA2024667C Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma |
| 07/31/2001 | CA1341279C Use of fluorescent benzothiazole derivatives |
| 07/27/2001 | CA2332657A1 A method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
| 07/26/2001 | WO2001053838A1 Method for quantitating creatinine discharged in urine, method for measuring urine component and apparatus therefor |
| 07/26/2001 | WO2001053837A1 Insulin-like growth factor system and cancer |
| 07/26/2001 | WO2001053836A2 Identification, assessment, prevention, and therapy of prostate cancer |
| 07/26/2001 | WO2001053835A2 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | WO2001053834A2 Detection of pathological defects in cells |
| 07/26/2001 | WO2001053833A1 Mage antigenic peptides which bind hla-b35 and hla-b44 |
| 07/26/2001 | WO2001053832A1 Method for examination of bronchial asthma attack and examination kit |
| 07/26/2001 | WO2001053831A1 Integrated support, integrated micro-container and permeable membrane, and method for production thereof and use thereof |
| 07/26/2001 | WO2001053830A2 Diagnostic method involving haemoglobin, haematocrit or reg blood cell count |
| 07/26/2001 | WO2001053829A1 Lipoprotein assay |
| 07/26/2001 | WO2001053828A1 Measurement apparatus and technique for properties of board products |
| 07/26/2001 | WO2001053827A1 Device for component metallographic testing |
| 07/26/2001 | WO2001053826A1 Food contamination detection system for vacuum packaged food products |
| 07/26/2001 | WO2001053825A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | WO2001053824A1 Mouse model for rheumatoid arthritis |
| 07/26/2001 | WO2001053823A1 Method of detecting or quantifying environmental hormones |
| 07/26/2001 | WO2001053817A2 Methods of and apparatus for separating and detecting nucleic acid |
| 07/26/2001 | WO2001053814A2 Gas sensor with a gel layer for determination of moisture content |
| 07/26/2001 | WO2001053813A1 Coking propensity test apparatus and method |
| 07/26/2001 | WO2001053812A1 Method of determining the degree of modification of a heat modified woodproduct |
| 07/26/2001 | WO2001053806A1 Apparatus, sample cuvette and method for optical measurements |
| 07/26/2001 | WO2001053804A1 Non-invasive in-vivo tissue classification using near-infrared measurements |
| 07/26/2001 | WO2001053796A1 Method for measuring the concentration or the partial pressure of gases, especially oxygen, in fluids and a corresponding gas sensor |
| 07/26/2001 | WO2001053792A2 A system for detecting substances |
| 07/26/2001 | WO2001053784A1 Imaging and analyzing parameters of small moving objects such as cells |
| 07/26/2001 | WO2001053607A2 Method for manufacturing concrete |
| 07/26/2001 | WO2001053539A1 Sensitive, multiplexed diagnostic assays for protein analysis |
| 07/26/2001 | WO2001053534A2 Method of identifying the function of a test agent |
| 07/26/2001 | WO2001053532A2 Barcoded synthetic lethal screening to identify drug targets |
| 07/26/2001 | WO2001053530A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053527A1 Method of detecting dna by dna hybridization method with the use of fluorescent resonance energy transfer |
| 07/26/2001 | WO2001053526A2 Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions |
| 07/26/2001 | WO2001053525A2 Cell isolation method |
| 07/26/2001 | WO2001053523A1 Method for synthesising and immobilising nucleic acids on a silanized solid support |
| 07/26/2001 | WO2001053520A2 Gene chip for neonate screening |
| 07/26/2001 | WO2001053518A2 Method of assessing the viability of a cell |
| 07/26/2001 | WO2001053517A1 Automatic water toxicity measuring apparatus |
| 07/26/2001 | WO2001053509A2 Biocidal molecules, macromolecular targets and methods of production and use |
| 07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | WO2001053469A2 Phosphatases |
| 07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 07/26/2001 | WO2001053464A1 Method and system for determining parameters of a protocol for deferred use of immunocompetent cells |
| 07/26/2001 | WO2001053450A1 Nipple aspirate fluid specific microarrays |
| 07/26/2001 | WO2001053355A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | WO2001053352A2 Sperm specific proteins |
| 07/26/2001 | WO2001053349A2 Small cell lung cancer associated antigens and uses therefor |
| 07/26/2001 | WO2001053348A2 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053339A2 Egg specific surface proteins |
| 07/26/2001 | WO2001053338A2 Cbp86, a sperm specific protein |
| 07/26/2001 | WO2001052987A1 Contacting device |
| 07/26/2001 | WO2001052905A1 Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan |
| 07/26/2001 | WO2001052904A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 07/26/2001 | WO2001052741A1 Luminescent in vivo glucose measurement |
| 07/26/2001 | WO2001052718A2 Diet and activity monitoring device |
| 07/26/2001 | WO2001052614A2 Selecting and producing t cell peptide epitopes |
| 07/26/2001 | WO2001052612A2 Method for isolating proteins or protein and nucleic acid associations, and resulting complexes of particles and proteins |
| 07/26/2001 | WO2001025476A8 Simultaneous enzymatic detection of two analytes |
| 07/26/2001 | WO2001018538A3 Miscible liquid capacitive sensing system |
| 07/26/2001 | WO2001014886A3 Inhibitors of binding between proteins and macromolecular ligands |
| 07/26/2001 | WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby |
| 07/26/2001 | WO2001007584A8 Controlled electroporation and mass transfer across cell membranes |
| 07/26/2001 | WO2001004264A3 Atherosclerosis-associated genes |
| 07/26/2001 | WO2001002583A3 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 07/26/2001 | WO2001002093A3 Detection article having fluid control film with capillary channels |
| 07/26/2001 | WO2001001129A3 Reverse transcriptase assay kit, use thereof and method for analysis of rt activity in biological samples |
| 07/26/2001 | WO2001000876A9 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000078933A3 Novel calpains and their use |